Logo
x

Search

Subscribe Now

2018

Janssen Discontinues its 2018 License Agreement with Argenx for Cusatuzumab

Janssen Discontinues its 2018 License Agreement with Argenx for Cusatuzumab

  • June 8, 2021
AbbVie Terminates Tau and ASN Agreement with Voyager Signed in 2018 and 2019

AbbVie Terminates Tau and ASN Agreement with Voyager Signed in 2018 and 2019

  • August 5, 2020
Sanofi Expands its 2018 Collaboration with Translate Bio to Develop mRNA Vaccines Against Infectious Diseases

Sanofi Expands its 2018 Collaboration with Translate Bio to Develop mRNA Vaccines Against Infectious Diseases

  • June 23, 2020
Roche and Cipla Expand Their 2018 Agreement to Improve Access of Oncology Therapies in India

Roche and Cipla Expand Their 2018 Agreement to Improve Access of Oncology Therapies in India

  • June 19, 2020
Tetra Therapeutics and Shionogi Expand their Existing 2018 Collaboration to Develop and Commercialize BPN14770

Tetra Therapeutics and Shionogi Expand their Existing 2018 Collaboration to Develop and Commercialize BPN14770

  • March 9, 2020
Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018

Sierra Oncology Amends its Asset Purchase Agreement with Gilead for Momelotinib Signed in 2018

  • November 8, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.